156 related articles for article (PubMed ID: 24250531)
1. Statistical Optimization of Oral Vancomycin-Eudragit RS Nanoparticles Using Response Surface Methodology.
Delf Loveymi B; Jelvehgari M; Zakeri-Milani P; Valizadeh H
Iran J Pharm Res; 2012; 11(4):1001-12. PubMed ID: 24250531
[TBL] [Abstract][Full Text] [Related]
2. Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability.
Loveymi BD; Jelvehgari M; Zakeri-Milani P; Valizadeh H
Adv Pharm Bull; 2012; 2(1):43-56. PubMed ID: 24312770
[TBL] [Abstract][Full Text] [Related]
3. Formulation Optimization of Human Insulin Loaded Microspheres for Controlled Oral Delivery Using Response Surface Methodology.
Agrawal G; Wakte P; Shelke S
Endocr Metab Immune Disord Drug Targets; 2017; 17(2):149-165. PubMed ID: 28472911
[TBL] [Abstract][Full Text] [Related]
4. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
5. Effects of process variables on micromeritic properties and drug release of non-degradable microparticles.
Jelvehgari M; Barar J; Nokhodchi A; Shadrou S; Valizadeh H
Adv Pharm Bull; 2011; 1(1):18-26. PubMed ID: 24312752
[TBL] [Abstract][Full Text] [Related]
6. Preparation, Optimization and In vitro Evaluation of Glipizide Nanoparticles Integrated with Eudragit RS-100.
Saharan P; Bahmani K; Saharan SP
Pharm Nanotechnol; 2019; 7(1):72-85. PubMed ID: 30892168
[TBL] [Abstract][Full Text] [Related]
7. Optimization of polymeric nano drug delivery system using 3(2) full factorial design.
Daspaul S; Mazumder R; Bhattacharya S; Jha AK
Curr Drug Deliv; 2013 Aug; 10(4):394-403. PubMed ID: 23013286
[TBL] [Abstract][Full Text] [Related]
8. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
Devarajan PV; Sonavane GS
Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
[TBL] [Abstract][Full Text] [Related]
9. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization.
Adibkia K; Javadzadeh Y; Dastmalchi S; Mohammadi G; Niri FK; Alaei-Beirami M
Colloids Surf B Biointerfaces; 2011 Mar; 83(1):155-9. PubMed ID: 21130612
[TBL] [Abstract][Full Text] [Related]
10. Formulation and characterizations of delayed release multi particulates system of indomethacin: optimization by response surface methodology.
Nandy BC; Mazumder B
Curr Drug Deliv; 2014; 11(1):72-86. PubMed ID: 24783236
[TBL] [Abstract][Full Text] [Related]
11. Statistical optimization of controlled release microspheres containing cetirizine hydrochloride as a model for water soluble drugs.
El-Say KM; El-Helw AR; Ahmed OA; Hosny KM; Ahmed TA; Kharshoum RM; Fahmy UA; Alsawahli M
Pharm Dev Technol; 2015; 20(6):738-46. PubMed ID: 24856961
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation.
Yousry C; Fahmy RH; Essam T; El-Laithy HM; Elkheshen SA
Drug Dev Ind Pharm; 2016 Nov; 42(11):1752-62. PubMed ID: 27093938
[TBL] [Abstract][Full Text] [Related]
13. Development and Optimization of Acriflavine-Loaded Polycaprolactone Nanoparticles Using Box-Behnken Design for Burn Wound Healing Applications.
Nawaz T; Iqbal M; Khan BA; Nawaz A; Hussain T; Hosny KM; Abualsunun WA; Rizg WY
Polymers (Basel); 2021 Dec; 14(1):. PubMed ID: 35012125
[TBL] [Abstract][Full Text] [Related]
14. Exploration of statistical experimental design to improve entrapment efficiency of acyclovir in poly (d, l) lactide nanoparticles.
Patel PJ; Gohel MC; Acharya SR
Pharm Dev Technol; 2014 Mar; 19(2):200-12. PubMed ID: 23432525
[TBL] [Abstract][Full Text] [Related]
15. Development of Eudragit RS 100 Microparticles Loaded with Ropinirole: Optimization and In Vitro Evaluation Studies.
Kashif PM; Madni A; Ashfaq M; Rehman M; Mahmood MA; Khan MI; Tahir N
AAPS PharmSciTech; 2017 Jul; 18(5):1810-1822. PubMed ID: 27830514
[TBL] [Abstract][Full Text] [Related]
16. Brimonidine tartrate-eudragit long-acting nanoparticles: formulation, optimization, in vitro and in vivo evaluation.
Bhagav P; Upadhyay H; Chandran S
AAPS PharmSciTech; 2011 Dec; 12(4):1087-101. PubMed ID: 21879393
[TBL] [Abstract][Full Text] [Related]
17. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
18. Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method.
Jelvehgari M; Nokhodchi A; Rezapour M; Valizadeh H
Indian J Pharm Sci; 2010 Jan; 72(1):72-8. PubMed ID: 20582193
[TBL] [Abstract][Full Text] [Related]
19. Quality by Design Based Fabrication of Iron Oxide Induced Mucoadhesive Microspheres for Enhanced Bioavalibility of Cinnarizine.
Singh I; Kamboj S; Rana V
Curr Drug Deliv; 2017; 14(8):1154-1169. PubMed ID: 27758691
[TBL] [Abstract][Full Text] [Related]
20. Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride.
Park SJ; Choo GH; Hwang SJ; Kim MS
Arch Pharm Res; 2013 May; 36(5):593-601. PubMed ID: 23446651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
